CDMO News
Porton Partners with Aojin for XDC Conjugate Drug Development
Porton Pharma Solutions, a prominent CDMO, has announced a strategic partnership with Aojin to support the development of XDC conjugate drugs. This collaboration encompasses pharmaceutical CMC research and GMP production, with the goal of filing dual IND applications in China
13 December 2024